Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
7 Espresso Machines for Home Baristas - 2Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- 3Nitty gritty Manual for Picking Agreeable Tennis shoes
- 4Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- 5Find the Lively Food Markets of South America
- One-third of asylum applications by Iranians approved in Germany
- Tens of thousands protest as far-right AfD forms new youth group
- How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
- WHO suspends Gaza medical evacuations after contractor killed by Israeli troops
- Alice Wong, founder of the Disability Visibility Project, dies at 51
- Fundamental Venture The board Apparatuses for Remote Groups
- Polar bears are rewiring their own genetics to survive a warming climate
- Ancient fire discovery marks significant milestone in human history
- Exploring Asia’s Realm of Flying Snakes
